The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 9, 1996, Pages 3984-3989

  Skaper, S D ^a   Buriani, A ^a   Dal Toso, R ^a   Petrelii, L ^a   Romanello, S ^a   Facci, L ^a   Leon, A ^a  

^a Ospedale Civile   (Italy)

Author keywords

N acylethanolamides; N methyl D aspartate; neuroprotection; neurotoxicity; receptor

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DELTA8 TETRAHYDROCANNABINOL; ETHANOLAMINE DERIVATIVE; GLUTAMIC ACID; PALMIDROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GRANULE CELL; IN SITU HYBRIDIZATION; MAST CELL; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACIDS; BASE SEQUENCE; CANNABINOIDS; CELLS, CULTURED; CEREBELLUM; DIZOCILPINE MALEATE; GLUTAMIC ACID; IN SITU HYBRIDIZATION; KINETICS; MICE; MICE, INBRED BALB C; MODELS, NEUROLOGICAL; MOLECULAR SEQUENCE DATA; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; OLIGONUCLEOTIDE PROBES; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; TIME FACTORS;

EID: 0029870716     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.9.3984     Document Type: Article

References (57)

1. Cotman, C. W., Monaghan, D. T., Offersen, O. P. & Storm-Mathisen, J. (1987) Trends Neurosci. 10, 273-280.
2. Gasic, G. P. & Hollmann, M. (1992) Annu. Rev. Physiol. 54, 507-536.
3. Collingridge, G. & Bliss, T. V. P. (1987) Trends Neurosci. 10, 288-294.
4. Lipton, S. A. & Kater, S. B. (1989) Trends Neurosci. 12, 265-270.
5. Choi, D. W. (1988) Neuron 1, 623-634.
6. Choi, D. W. & Rothman, S. M. (1990) Annu. Rev. Neurosci. 13, 171-182.
7. DiFiglia, M. (1990) Trends Neurosci. 13, 286-289.
8. Meldrum, B. & Garthwaite, J. (1990) Trends Pharmacol. Sci. 11, 379-387.
9. Lipton, S. A. & Rosenberg, P. A. (1994) N. Engl. J. Med. 330, 613-622.
10. Koh, J. Y., Goldberg, M. P., Hartley, D. M. & Choi, D. W. (1990) J. Neurosci. 10, 693-705.
11. Sheardown, M. J., Nielsen, E. O., Hansen, A. J., Jacobsen, P. & Honóre, T. (1990) Science 247, 571-574.
12. Schmid, H. H. O., Schmid, P. C. & Natarajan, V. (1990) Prog. Lipid Res. 29, 1-43.
13. Natarajan, V., Schmid, P. C. & Schmid, H. H. O. (1986) Biochim. Biophys. Acta 878, 32-41.
14. Epps, D. E., Natarajan, V., Schmid, P. C. & Schmid, H. H. O. (1980) Biochim. Biophys. Acta 618, 420-430.
15. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C. & Piomelli, D. (1994) Nature (London) 372, 686-691.
16. Hansen, H. A., Lauritzen, L., Strand, A. M., Moesgaard, B. & Frandsen, A. (1995) Biochim. Biophys. Acta 1258, 303-308.
17. Hollister, L. E. (1986) Pharmacol. Rev. 38, 1-20.
18. Munro, S., Thomas, K. L. & Abu-Shaar, M. (1993) Nature (London) 365, 61-65.
19. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D. & Leon, A. (1995) Proc. Natl. Acad. Sci. USA 92, 3376-3380.
20. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. (1990) Nature (London) 346, 561-564.
21. Gérard, C. M., Mollereau, C., Vassart, G. & Parmentier, M. (1991) Biochem. J. 279, 129-134.
22. Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Science 258, 1946-1949.
23. Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K. & Devane, W. A. (1993) Proc. Natl. Acad. Sci. USA 90, 7656-7660.
24. Skaper, S. D., Facci, L., Milani, D., Leon, A. & Toffano, G. (1990) in Methods in Neurosciences, ed. Conn, P. M. (Academic, San Diego), Vol. 2, pp. 17-33.
25. Levi, G., Aloisi, F., Ciotti, M. T. & Gallo, V. (1984) Brain Res. 290, 77-86.
26. Mossmann, T. (1983) J. Immunol. Methods 65, 55-63.
27. Manthorpe, M., Fagnani, R., Skaper, S. D. & Varon, S. (1986) Dev. Brain Res. 25, 191-198.
28. Ohsawa, F., Widmer, H. R., Knusel, B., Denton, T. L. & Hefti, F. (1993) Neuroscience 57, 67-77.
29. Patel, J., Zinkand, W. C., Thompson, C., Keith, R. & Salama, A. (1990) J. Neurochem. 54, 849-854.
30. Cosi, C., Spoerri, P. E., Comelli, C., Guidolin, D. & Skaper, S. D. (1993) NeuroReport 4, 527-530.
31. Devane, W. A., Dysarz, F. A., III, Johnson, M. R., Melvin, L. S. & Howlett, A. C. (1988) Mol. Pharmacol. 34, 605-613.
32. Watkins, J. C. & Olverman, H. J. (1987) Trends Neurosci. 10, 265-272.
33. Choi, D. W., Koh, J.-Y. & Peters, S. (1988) J. Neurosci. 8, 185-196.
34. Hartley, D. M. & Choi, D. W. (1989) J. Pharmacol. Exp. Ther. 250, 752-758.
35. Csernansky, C. A., Canzoniero, L. M. T., Sensi, S. L., Yu, S. H. & Choi, D. W. (1994) J. Neurosci. Res. 38, 101-108.
36. Wong, E. H., Kemp, J. A., Priestley, T., Knight, A. R., Woodruff, G. N. & Iversen, L. L. (1986) Proc. Natl. Acad. Sci. USA 83, 7104-7108.
37. Crawley, J. N., Corwin, R. L., Robinson, J. K., Felder, C. C., Devane, W. A. & Axelrod, J. (1993) Pharmacol. Biochem. Behav. 46, 967-972.
38. Smith, P. B., Compton, D. R., Welch, S. P., Razdan, R. K., Mechoulam, R. & Martin, B. R. (1994) J. Pharmacol. Exp. Ther. 270, 219-227.
39. Deutsch, D. G. & Chin, S. (1993) Biochem. Pharmacol. 46, 791-796.
40. Nadler, V., Mechoulam, R. & Sokolovsky, M. (1993) Neurosci. Lett. 162, 43-45.
41. Puttfarcken, P. S., Getz, R. L. & Coyle, J. T. (1993) Brain Res. 624, 223-232.
42. Kato, K., Puttfarcken, P. S., Lyons, W. E. & Coyle, J. T. (1991) J. Pharmacol. Exp. Ther. 256, 402-411.
43. Gallo, V., Kingsbury, A., Balázs, R. & Jørgensen, O. S. (1987) J. Neurosci. 7, 2203-2213.
44. Balázs, R., Jorgensen, O. S. & Hack, N. (1988) Neuroscience 27, 437-451.
45. Rosenthal, H. E. (1967) Anal. Biochem. 20, 525-532.
46. Hillard, C. J., Edgemond, W. S. & Campbell, W. B. (1995) J. Neurochem. 64, 677-683.
47. Howlett, A. C. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 607-634.
48. Lynn, A. B. & Herkenham, M. (1994) J. Pharmacol. Exp. Ther. 268, 1612-1623.
49. Pacheco, M. A., Ward, S. J. & Childers, S. R. (1993) Brain Res. 603, 102-110.
50. Aronica, E., Dell'Albani, P., Condorelli, D. F., Nicoletti, F., Hack, N. & Balázs, R. (1993) Mol. Pharmacol. 44, 981-989.
51. Paschen, W., Schmitt, J. & Uto, A. (1995) Soc. Neurosci. Abstr. 21, 765.
52. Shen, M., Piser, T. M. & Thayer, S. A. (1995) Soc. Neurosci. Abstr. 21, 1569.
53. Lipton, S. A. (1993) Trends Neurosci. 16, 527-532.
54. Choi, D. W. (1990) Cerebrovasc. Brain Metab. Rev. 2, 105-147.
55. Mercanti, D., Galli, C., Liguori, M., Ciotti, M. T., Gullà, P. & Calissano, P. (1992) Eur. J. Neurosci. 4, 733-744.
56. Aloe, L., Leon, A. & Levi-Montalcini, R. (1993) Agents Actions 39, C145-C147.
57. Mazzari, S., Canella, R., Petrelli, L., Marcolongo, G. & Leon, A. (1996) Eur. J. Pharmacol., in press.